23.05.2017
- AstraZeneca has sold European rights for its Seloken/Seloken ZOK and Logimax cardiovascular drugs to Italy’s Recordati for $300 million. The medicines, which are used to treat...
29.07.2014
- Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...
